The Alphabet and Tencent-backed automation software producer, valued at $35bn as of last month, has filed for a $1bn offering.

The Novo-backed musculoskeletal disease therapy developer floated in an upsized IPO before its share price almost doubled on its first day of trading.

Bristol Myers Squibb has scored an exit from oncology therapy deveoper Ikena, whose share priced doubled on its first day of trading.

Rock Solid Technologies is purchasing the meeting management platform developer in a deal allowing Propylon to exit.

The supply chain financing platform has filed to raise up to $1.06bn in a Hong Kong Stock Exchange offering which will enable Bertelsmann, GLP, Skyworth and Tencent to exit.

The online question-and-answer platform developer is going public alongside a $250m private placement featuring JD.com, Alibaba, Tencent and Lilith Games.

Hanwha and SoftBank could exit the advanced biomaterials developer in the offering, which will follow more than $870m in funding.

The SoftBank-backed automotive e-commerce platform developer priced its initial public offering above the range and hit a $4.8bn valuation yesterday.

The Petronas and TNSC-backed 3D printing tedchnology provider has agreed to list through a reverse takeover deal at a $1.6bn valuation.

Bayer could exit the drug discovery technology developer should it complete an initial public offering on the Nasdaq Global Select Market.